7
total announcements
VIVIMEDLAB.NS · 15 min delayed
Vivimed Labs Limited
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process and scheduled the 6th meeting of the Committee of Creditors on August 18, 2026.
Vivimed Labs Limited
Vivimed Labs Limited has been asked by the Exchange to clarify its financial results for the quarter ended 31-Dec-2025, specifically regarding Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has not yet responded to the query.
Vivimed Labs Limited
Vivimed Labs Limited has informed the Exchange regarding the re-lodgement of transfer requests of physical shares as per SEBI Circular No. SEBI/HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated 30th January, 2026.
Vivimed Labs Limited
Vivimed Labs Limited has informed the Exchange about General Updates, specifically regarding the newspaper publication of financial results for the quarter and year ended March 31, 2026.
Vivimed Labs Limited
Vivimed Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended 30 June, 2026.
Vivimed Labs Limited
Vivimed Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from 01.07.2026 till 48 hours after the declaration of the Financial Results for the quarter ended June 30, 2026.
Vivimed Labs Limited
Vivimed Labs Limited has responded to the National Stock Exchange's (NSE) clarification request regarding its financial results for the quarter ended March 31, 2025. The company clarified that the financial results were not submitted in the prescribed format, and there were technical issues with scanning and filing the documents, resulting in a delay in uploading the results.